CYP3A4*22 may increase bleeding risk in ticagrelor users.
Basic Clin Pharmacol Toxicol
; 133(2): 202-207, 2023 08.
Article
in En
| MEDLINE
| ID: mdl-37162098
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Acute Coronary Syndrome
/
Percutaneous Coronary Intervention
Type of study:
Etiology_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Basic Clin Pharmacol Toxicol
Journal subject:
FARMACOLOGIA
/
TOXICOLOGIA
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: